Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-11 5:27 pm Purchase | 2020-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | BIOTECHNOLOGY VALUE FUND L P | 5,576,471 12.100% | 950,060 (+20.54%) | Filing History |
| 2021-02-11 5:25 pm Sale | 2020-12-31 | 13G | Calithera Biosciences, Inc. CALA | BIOTECHNOLOGY VALUE FUND L P | 218,062 6.200% | -136,470 (-38.49%) | Filing History |
| 2021-02-11 5:23 pm Sale | 2020-12-31 | 13G | Molecular Templates, Inc. MTEM | BIOTECHNOLOGY VALUE FUND L P | 184,075 5.500% | -56,481 (-23.48%) | Filing History |
| 2021-02-11 5:20 pm Purchase | 2020-12-31 | 13G | ESSA Pharma Inc. EPIX | BIOTECHNOLOGY VALUE FUND L P | 3,705,289 11.000% | 1,064,724 (+40.32%) | Filing History |
| 2021-02-11 5:18 pm Sale | 2020-12-31 | 13G | Forward Pharma A/S FWPAY | BIOTECHNOLOGY VALUE FUND L P | 35,771 10.700% | -13,677 (-27.66%) | Filing History |
| 2021-02-11 5:16 pm Sale | 2020-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | BIOTECHNOLOGY VALUE FUND L P | 50 1.000% | -3,079,105 (-100.00%) | Filing History |
| 2021-02-11 5:14 pm Purchase | 2020-12-31 | 13G | GlycoMimetics, Inc. GLYC | BIOTECHNOLOGY VALUE FUND L P | 95,443 19.960% | 21,825 (+29.65%) | Filing History |
| 2021-02-11 5:12 pm Sale | 2020-12-31 | 13G | Replimune Group, Inc. REPL | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,309,109 (Position Closed) | Filing History |
| 2021-02-11 5:10 pm Sale | 2020-12-31 | 13G | Surface Oncology, Inc. SURF | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,125,650 (Position Closed) | Filing History |
| 2021-02-11 5:08 pm Sale | 2020-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -3,755,553 (Position Closed) | Filing History |
| 2021-02-11 5:06 pm Purchase | 2020-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | BIOTECHNOLOGY VALUE FUND L P | 3,226,769 11.100% | 2,597 (+0.08%) | Filing History |
| 2021-02-11 4:59 pm Sale | 2020-12-31 | 13G | Kura Oncology, Inc. KURA | BIOTECHNOLOGY VALUE FUND L P | 1,245,912 1.900% | -1,188,784 (-48.83%) | Filing History |
| 2021-02-11 4:52 pm Purchase | 2020-12-31 | 13G | Cogent Biosciences, Inc. COGT | BIOTECHNOLOGY VALUE FUND L P | 3,114,250 4.700% | 3,114,250 (New Position) | Filing History |
| 2021-02-11 4:43 pm Sale | 2020-12-31 | 13G | Curis, Inc. CRIS | BIOTECHNOLOGY VALUE FUND L P | 31,347 1.000% | -151,153 (-82.82%) | Filing History |
| 2021-02-11 4:41 pm Sale | 2020-12-31 | 13G | AnaptysBio, Inc. ANAB | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -1,441,565 (Position Closed) | Filing History |
| 2021-02-11 4:33 pm Sale | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,740,000 (Position Closed) | Filing History |
| 2021-02-11 4:30 pm Sale | 2020-12-31 | 13G | Brickell Biotech, Inc. BBI | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -14,757 (Position Closed) | Filing History |
| 2021-02-11 4:22 pm Purchase | 2020-12-31 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 931,750 6.600% | 404,333 (+76.66%) | Filing History |
| 2021-02-01 5:19 pm Purchase | 2021-01-22 | 13G | FIVE PRIME THERAPEUTICS INC FPRX | BIOTECHNOLOGY VALUE FUND L P | 3,138,678 7.200% | 1,875,000 (+148.38%) | Filing History |
| 2021-01-29 4:36 pm Sale | 2021-01-27 | 13D | PHAXIAM Therapeutics S.A. PHXM | BIOTECHNOLOGY VALUE FUND L P | 40,819 20.400% | -3,800 (-8.52%) | Filing History |